Status | Study |
Completed |
Study Name: Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials Condition: Pelvic Inflammatory Disease Date: 2013-02-16 Interventions: Drug: Moxifloxacin daily 400 m |
Recruiting |
Study Name: Surgical Success After Laparoscopic vs Abdominal Hysterectomy Condition: Metrorrhagia Menorrhagia Leiomyoma Date: 2013-02-13 Interventions: Procedure: Laparoscopic hysterectomy |
Completed |
Study Name: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) Condition: Pneumonia Pelvic Inflammatory Disease Date: 2012-08-20 Interventions: Drug: Azithromycin IV The recommended dose of ZITHROMAC (a |
Recruiting |
Study Name: Technology Enhanced Community Health Nursing (TECH-N) Study Condition: Pelvic Inflammatory Disease (PID) Date: 2012-07-11 Interventions: Behavioral: Technology Enhanced Community Health Nursing |
Completed |
Study Name: Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease Condition: Pelvic Inflammatory Disease Date: 2010-11-30 Interventions: Behavioral: Text Message Reminders Patients in the intervention group will receive text messages on thei |
Completed |
Study Name: To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment Condition: Pelvic Inflammatory Disease Date: 2010-11-15 Interventions: Drug: Ofloxacin group A, Azitromycin group B |
Completed |
Study Name: The Role of Novel Organisms in Acute Endometritis Condition: Pelvic Inflammatory Disease Date: 2010-11-04 Interventions: Other: no intervention Not Applicable- no intervention |
Completed |
Study Name: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) Condition: Pelvic Inflammatory Disease Date: 2010-07-08 Interventions: Drug: Ceftriaxone ceftrixone 2 |
Completed |
Study Name: Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan Condition: Pelvic Inflammatory Disease Date: 2009-03-27 Interventions: Drug: Azithromycin The patients will receive 500 mg intravenous azithromycin QD for 1 to 2 days. The per |
Completed |
Study Name: Rate of Pelvic Inflammatory Disease at St. Michael's Hospital Condition: Pelvic Inflammatory Disease Date: 2008-10-30 |